BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 36239840)

  • 1. Oncologic safety of axillary lymph node dissection with immediate lymphatic reconstruction.
    Guzzo HM; Valente SA; Schwarz GS; ElSherif A; Grobmyer SR; Cakmakoglu C; Djohan R; Bernard S; Lang JE; Pratt D; Al-Hilli Z
    Breast Cancer Res Treat; 2022 Dec; 196(3):657-664. PubMed ID: 36239840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of survival outcomes between axillary conservation and axillary lymph node dissections in N1 early breast cancer: a propensity-matched SEER analysis.
    Wu N; Su X; Tan Q; Luo J; Yuan Y; Hou L; Li J
    Clin Transl Oncol; 2023 Apr; 25(4):1091-1101. PubMed ID: 36515887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arm morbidity of axillary dissection with sentinel node biopsy versus delayed axillary dissection.
    Ballal H; Hunt C; Bharat C; Murray K; Kamyab R; Saunders C
    ANZ J Surg; 2018 Sep; 88(9):917-921. PubMed ID: 29392828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of immediate lymphatic reconstruction on the post-operative drain output after axillary lymph node dissection for breast cancer: A retrospective comparative study.
    Lin YS; Kuan CH; Tsai LW; Wu CH; Huang CH; Yeong EK; Tai HC; Huang CS
    Microsurgery; 2023 Sep; 43(6):555-562. PubMed ID: 36762663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating Operative Times for Intraoperative Conversion of Axillary Node Biopsy to Axillary Lymph Node Dissection with Immediate Lymphatic Reconstruction.
    Ahmed S; Hulsman L; Roth D; Fisher C; Ludwig K; Imeokparia FO; VonDerHaar RJ; Lester ME; Hassanein AH
    J Reconstr Microsurg; 2024 Jun; ():. PubMed ID: 38866037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymph Node Positivity of Axillary Reverse Mapping Lymph Nodes at the Time of Axillary Lymph Node Dissection: Two-Site Prospective Trial.
    Benolken MM; McLaughlin S; Piltin M; Mrdutt M; Li Z; Jakub JW
    Ann Surg Oncol; 2023 Oct; 30(10):6042-6049. PubMed ID: 37466868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using the axillary reverse mapping technique to screen breast cancer patients with a high risk of lymphedema.
    Liu S; Wang N; Gao P; Liu P; Yang H; Xie F; Wang S; Liu M; Wang S
    World J Surg Oncol; 2020 Jun; 18(1):118. PubMed ID: 32482174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preservation of Axillary Lymph Nodes Compared with Complete Dissection in T1-2 Breast Cancer Patients Presenting One or Two Metastatic Sentinel Lymph Nodes: The SINODAR-ONE Multicenter Randomized Clinical Trial.
    Tinterri C; Gentile D; Gatzemeier W; Sagona A; Barbieri E; Testori A; Errico V; Bottini A; Marrazzo E; Dani C; Dozin B; Boni L; Bruzzi P; Fernandes B; Franceschini D; Spoto R; Torrisi R; Scorsetti M; Santoro A; Canavese G;
    Ann Surg Oncol; 2022 Sep; 29(9):5732-5744. PubMed ID: 35552930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sentinel lymph node biopsy following previous axillary surgery in recurrent breast cancer.
    Sávolt Á; Cserni G; Lázár G; Maráz R; Kelemen P; Kovács E; Győrffy B; Udvarhelyi N; Vörös A; Ormándi K; Mátrai Z
    Eur J Surg Oncol; 2019 Oct; 45(10):1835-1838. PubMed ID: 31126680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimize the extent and morbidity of axillary dissection for node-positive breast cancer patients: implementation of axillary lymph node dissection based on breast lymphatics level.
    Yuan Q; Hou J; He Y; Liao Y; Zheng L; Wu G
    BMC Cancer; 2021 Mar; 21(1):293. PubMed ID: 33740930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Identification and preservation of arm lymphatics in axillary lymph node dissection to prevent arm lymphedema: a single center randomized controlled trial].
    Yuan QQ; Wu GS; Hou JX; Zheng LW; Liao YQ; He YK
    Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):430-435. PubMed ID: 35615800
    [No Abstract]   [Full Text] [Related]  

  • 12. Conservative axillary surgery in breast cancer patients undergoing mastectomy: long-term results.
    Cowher MS; Grobmyer SR; Lyons J; O'Rourke C; Baynes D; Crowe JP
    J Am Coll Surg; 2014 Apr; 218(4):819-24. PubMed ID: 24655877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of the Axilla in T1-2 Breast Cancer Patients with Macrometastatic Sentinel Node Involvement Who Underwent Breast-Conserving Therapy.
    Kuru B; Yuruker S; Sullu Y; Gursel B; Ozen N
    J Invest Surg; 2019 Jan; 32(1):48-54. PubMed ID: 28945489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erratum to: Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up.
    Kiluk JV; Ly QP; Santillan AA; Meade T; Ramos D; Reintgen DS; Dessureault S; Davis M; Shamehdi C; Cox CE
    Ann Surg Oncol; 2010 Feb; 17(2):552-7. PubMed ID: 19957043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility and oncological safety of sentinel node biopsy in breast cancer patients with a local recurrence.
    Biglia N; Bounous VE; Gallo M; Fuso L; Sgro LG; Maggiorotto F; Ponzone R
    Breast; 2018 Oct; 41():8-13. PubMed ID: 29933180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axillary lymph node dissection vs. sentinel node biopsy for early-stage clinically node-negative breast cancer: a systematic review and meta-analysis.
    Petousis S; Christidis P; Margioula-Siarkou C; Liberis A; Vavoulidis E; Margioula-Siarkou G; Vatopoulou A; Papanikolaou A; Mavromatidis G; Dinas K
    Arch Gynecol Obstet; 2022 Oct; 306(4):1221-1234. PubMed ID: 35249123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evolution of the sentinel node procedure in the treatment of breast cancer.
    Tvedskov TF
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
    Yegiyants S; Romero LM; Haigh PI; DiFronzo LA
    Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axillary reverse mapping (ARM): where to go.
    Shao X; Sun B; Shen Y
    Breast Cancer; 2019 Jan; 26(1):1-10. PubMed ID: 29961238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does Axillary Reverse Mapping Prevent Lymphedema After Lymphadenectomy?
    Tummel E; Ochoa D; Korourian S; Betzold R; Adkins L; McCarthy M; Hung S; Kalkwarf K; Gallagher K; Lee JY; Klimberg VS
    Ann Surg; 2017 May; 265(5):987-992. PubMed ID: 27163955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.